Mycogenic synthesis of silver nanoparticles using endophytic fungi and their characterization, biological activities, including in-silico studies with special reference to Fusarium wilt of tomato
- PMID: 40707118
- DOI: 10.1016/j.funbio.2025.101610
Mycogenic synthesis of silver nanoparticles using endophytic fungi and their characterization, biological activities, including in-silico studies with special reference to Fusarium wilt of tomato
Abstract
Nanoparticle research is currently a topic of significant scientific interest, due to its vast array of application in biological field. An effort was made to produce silver nanoparticles (AgNPs) from two endophytic fungi; Fusarium oxysporum (FoAgNPs) and Fusarium proliferatum (FpAgNPs), which were isolated from a Pteridophyte Pyrrosia lanceolata (L.) Farw. The AgNPs were characterised using UV-Vis spectroscopy, exhibiting sizes ranging from 3 nm to 27 nm and displaying a polycrystalline nature as determined by scanning and transmission microscopy, along with SAED pattern analysis. Additionally, we identify phenolic groups at 1067.12 cm-1 as the capping agent that facilitates the reduction of silver ions and stabilizes the nanoparticles evaluated via FTIR. The in vitro antibacterial potency AgNPs had the maximum activity against Escherichia fergusonii, followed by Proteus mirabilis; for both organisms, the minimum inhibitory concentration (MIC) value was 10 μg/ml. AgNPs also demonstrated strong antifungal activity against various plant pathogens, MIC was 15 μg/ml. Additionally, SEM analysis revealed that AgNPs caused pathogen hypha shrinkage and deformation, indicating structural deterioration in cellular and organelle structures due to ROS production. Further, the antifungal efficacy of manufactured AgNPs was investigated against F. oxysporum f.sp. lycopersici in Solanum lycopersicum, a plant pathogen affecting tomato growth and yield, and nano-formulation (150 ppm) completely prevented infection in the greenhouse settings. Biogenic AgNPs at 40 ppm enhanced root-shoot length in Vigna radiata seeds compared to untreated seeds, suggesting phyto-stimulatory action. The cytotoxicity assessment indicated that the synthesized AgNPs are safe for a variety of bio-applications. Furthermore, we chose NADPH Oxidase (F. oxysporum f.sp. lycopersici) as the protein to perform the molecular docking and results indicates that the active site of the selected protein serves as a critical region for inhibiting disease propagation. The study findings enhanced our knowledge of the antifungal properties and mechanisms of AgNPs, providing a novel perspective on utilising this antifungal alternative for the treatment of plant diseases.
Keywords: Endophytic fungi; Fusarium wilt of tomato; Mycosynthesis; ROS; Silvernanoparticles.
Copyright © 2025 British Mycological Society. Published by Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Biosynthesis and characterization of silver nanoparticles from Asplenium dalhousiae and their potential biological properties.PLoS One. 2025 Jun 30;20(6):e0325533. doi: 10.1371/journal.pone.0325533. eCollection 2025. PLoS One. 2025. PMID: 40587502 Free PMC article.
-
Host-specific adaptation in Fusarium oxysporum correlates with distinct accessory chromosome content in human and plant pathogenic strains.mBio. 2025 Aug 13;16(8):e0095125. doi: 10.1128/mbio.00951-25. Epub 2025 Jun 26. mBio. 2025. PMID: 40569077 Free PMC article.
-
Eco-friendly silver nanoparticles from garlic: a novel therapeutic approach for treating Escherichia fergusonii wound infections.Front Cell Infect Microbiol. 2025 Jun 30;15:1604507. doi: 10.3389/fcimb.2025.1604507. eCollection 2025. Front Cell Infect Microbiol. 2025. PMID: 40661972 Free PMC article.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources